Literature DB >> 27535484

Apo- and Antagonist-Binding Structures of Vitamin D Receptor Ligand-Binding Domain Revealed by Hybrid Approach Combining Small-Angle X-ray Scattering and Molecular Dynamics.

Yasuaki Anami1, Nobutaka Shimizu2, Toru Ekimoto3, Daichi Egawa1, Toshimasa Itoh1, Mitsunori Ikeguchi3, Keiko Yamamoto1.   

Abstract

Vitamin D receptor (VDR) controls the expression of numerous genes through the conformational change caused by binding 1α,25-dihydroxyvitamin D3. Helix 12 in the ligand-binding domain (LBD) is key to regulating VDR activation. The structures of apo VDR-LBD and the VDR-LBD/antagonist complex are unclear. Here, we reveal their unprecedented structures in solution using a hybrid method combining small-angle X-ray scattering and molecular dynamics simulations. In apo rat VDR-LBD, helix 12 is partially unraveled, and it is positioned around the canonical active position and fluctuates. Helix 11 greatly bends toward the outside at Q396, creating a kink. In the rat VDR-LBD/antagonist complex, helix 12 does not generate the activation function 2 surface, and loop 11-12 is remarkably flexible compared to that in the apo rat VDR-LBD. On the basis of these structural insights, we propose a "folding-door model" to describe the mechanism of agonism/antagonism of VDR-LBD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27535484     DOI: 10.1021/acs.jmedchem.6b00682

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

Review 1.  Alternative binding sites at the vitamin D receptor and their ligands.

Authors:  Tania R Mutchie; Olivia B Yu; Elliot S Di Milo; Leggy A Arnold
Journal:  Mol Cell Endocrinol       Date:  2019-01-14       Impact factor: 4.102

2.  A multidisciplinary approach disclosing unexplored Aflatoxin B1 roles in severe impairment of vitamin D mechanisms of action.

Authors:  Marco Persico; Raffaele Sessa; Elena Cesaro; Irene Dini; Paola Costanzo; Alberto Ritieni; Caterina Fattorusso; Michela Grosso
Journal:  Cell Biol Toxicol       Date:  2022-09-06       Impact factor: 6.819

Review 3.  Strategies for developing pregnane X receptor antagonists: Implications from metabolism to cancer.

Authors:  Sergio C Chai; William C Wright; Taosheng Chen
Journal:  Med Res Rev       Date:  2019-11-28       Impact factor: 12.944

4.  An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position.

Authors:  Paulo C T Souza; Larissa C Textor; Denise C Melo; Alessandro S Nascimento; Munir S Skaf; Igor Polikarpov
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

Review 5.  Vitamin D and Its Synthetic Analogs.

Authors:  Miguel A Maestro; Ferdinand Molnár; Carsten Carlberg
Journal:  J Med Chem       Date:  2019-04-02       Impact factor: 7.446

6.  Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonist.

Authors:  Azam Rashidian; Enni-Kaisa Mustonen; Thales Kronenberger; Matthias Schwab; Oliver Burk; Stefan A Laufer; Tatu Pantsar
Journal:  Comput Struct Biotechnol J       Date:  2022-06-13       Impact factor: 6.155

7.  Multidomain architecture of estrogen receptor reveals interfacial cross-talk between its DNA-binding and ligand-binding domains.

Authors:  Wei Huang; Yi Peng; Janna Kiselar; Xuan Zhao; Aljawharah Albaqami; Daniel Mendez; Yinghua Chen; Srinivas Chakravarthy; Sayan Gupta; Corie Ralston; Hung-Ying Kao; Mark R Chance; Sichun Yang
Journal:  Nat Commun       Date:  2018-08-30       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.